Phase II Palbociclib +Ibrutinib in Mantle Cell Lymphoma

NCT03478514 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Mantle Cell Lymphoma
B Cell Lymphoma

Interventions

DRUG: Palbociclib
DRUG: Ibrutinib

Sponsor

Alliance Foundation Trials, LLC.

Collaborators

[object Object]